Kiniksa Pharmaceuticals Ltd Strategic Asset Allocation Index
Kiniksa Pharmaceuticals Ltd strategic asset allocation index. Kiniksa Pharmaceuticals Ltd (KNSA) has a Strategic Asset Allocation Index of 3.4% as of September 2023. Strategic assets (PP&E of $13.59 Million plus long-term investments of $-) total $13.59 Million, measured against net assets of $405.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible equity quality of Kiniksa Pharmaceuticals Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Kiniksa Pharmaceuticals Ltd (2018–2022)
Strategic asset allocation index of Kiniksa Pharmaceuticals Ltd from 2018 to 2022. This chart shows how Kiniksa Pharmaceuticals Ltd's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the index stands at 3.4%, representing strategic assets of $13.59 Million against net assets of $405.13 Million USD.
Kiniksa Pharmaceuticals Ltd Strategic Asset Allocation Index by Year (2018–2022)
Kiniksa Pharmaceuticals Ltd strategic asset allocation index by year from 2018 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Kiniksa Pharmaceuticals Ltd from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see KNSA market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.4% | $1.66 Million | $1.66 Million | $- | $396.15 Million | ▼ -1.1 pp |
| 2021 | 1.5% | $2.83 Million | $2.83 Million | $- | $185.04 Million | ▲ +0.2 pp |
| 2020 | 1.3% | $4.05 Million | $4.05 Million | $- | $311.94 Million | ▼ -2.4 pp |
| 2019 | 3.7% | $8.32 Million | $8.32 Million | $- | $225.42 Million | ▲ +1.4 pp |
| 2018 | 2.3% | $6.36 Million | $6.36 Million | $- | $279.27 Million | — |